Rapport Therapeutics (RAPP) vs Syndax Pharmaceuticals (SNDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Rapport Therapeutics (RAPP) has outperformed Syndax Pharmaceuticals (SNDX) over the past year, gaining 16.7% versus a gain of 3.5%. Syndax Pharmaceuticals is the larger company by market cap ($1.52 billion vs $1.48 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RAPP | SNDX |
|---|---|---|
| Share price | $30.86 | $17.03 |
| Market cap | $1.48B | $1.52B |
| 1-day change | -0.93% | -1.96% |
| YTD return | +1.71% | -18.94% |
| 1-year return | +16.72% | +3.53% |
| 5-year return | — | -8.39% |
| EPS (TTM) | $-3.03 | $-2.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $52.93 | $25.59 |
| 52-week low | $23.75 | $12.99 |
| Distance from 52-week high | -41.70% | -33.45% |
| Average volume | 370.01K | 1.58M |
| Shares outstanding | 47.98M | 89.30M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RAPP has outperformed SNDX by 13.2 percentage points over the past year.
RAPP vs SNDX FAQ
Which is bigger, Rapport Therapeutics or Syndax Pharmaceuticals?
Syndax Pharmaceuticals (SNDX) is larger, with a market capitalization of $1.52B compared with $1.48B for Rapport Therapeutics (RAPP).
Which stock has performed better over the past year, RAPP or SNDX?
RAPP returned +16.72% over the past 12 months, compared with +3.53% for SNDX (price return, excluding dividends). Past performance does not predict future results.
Are Rapport Therapeutics and Syndax Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.